Fitabeo Therapeutics has 鈥榮pun-out鈥� from the University of 黑料正能量 with plans to address some of society鈥檚 most pressing healthcare challenges within chronic pain and women鈥檚 health.
The company also announced the appointment of pharmaceutical executive Jodi Devlin as Chair of the Board.
Innovative medicines
The Edinburgh-based clinical-stage specialty pharmaceutical company develops and commercialises innovative medicines focusing on indications where existing treatments are inadequate for the target population to provide better health outcomes.
Mallikarjun Chityala, Fitabeo Founder and CEO said: 鈥淲e are excited about the opportunity to deploy breakthrough innovation to address some of society鈥檚 most pressing challenges and improve access to medicines across all age groups.
鈥淔itabeo Therapeutics鈥� portfolio will play a significant role in reducing the treatment burden by enhancing patient autonomy and medication adherence.
鈥淲e are grateful to have received phenomenal support from the Scottish entrepreneurial ecosystem. We are also pleased to have Jodi Devlin joining our board as Chair. Jodi brings a wealth of experience in pharmaceuticals and a broad industry network that will enhance the evolution of Fitabeo Therapeutics and help accelerate the development and commercialisation of assets working closely with the board.鈥�
黑料正能量 Inspire
The University of 黑料正能量 spin-out company, has been supported by 黑料正能量 Inspire, the University鈥檚 entrepreneurship initiative.
Dr Olga Kozlova, Director of Innovation and Industry Engagement at the University said: 鈥淲e are proud to have supported Fitabeo Therapeutics from the outset. It鈥檚 a great demonstration of how academic research can be translated into innovation with the potential to have a real global impact on people鈥檚 health and wellbeing.鈥�
Scottish Enterprise also supported the company via its High Growth Spin-out Programme, which helps university teams turn their innovative ideas into commercially successful high-growth businesses.
Leah Pape, Head of High Growth Services at Scottish Enterprise, said: 鈥淪adly, chronic pain and women鈥檚 health represent great areas of medical need, but with our support, Fitabeo is developing solutions to address the challenge of delivering improved quality of life for patients as well as showcasing Scottish innovation on the global stage.鈥�